YD Bio Limited
NASDAQWhy this matters: Three lending-market signals fired on YDES simultaneously. Cost to borrow hit a record high. Availability collapsed. Short interest nearly quintupled in a week. All of it happened while the stock surged 170%. The cost to borrow YDES has hit 141.1% — an all-time record for the name. That is more than four times the level…
YDES utilization surges to 96.36%, near its 52-week peak of 100%, as availability plummets to just 4.85%—making shares extremely difficult to borrow.
Short interest % of float, cost to borrow, utilization, and put/call ratio for YDES are part of the ORTEX premium tier. Sign up to read the live numbers alongside the analysis.
Snapshot as of 29 Sept 2026
Why this matters: Three lending-market signals fired on YDES simultaneously. Cost to borrow hit a record high. Availability collapsed. Short interest nearly quintupled in a week. All of it happened while the stock…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for YDES — free to start on ORTEX.
Sign up for free →Open YDES on ORTEXPulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live YDES data →